(Reuters) - Global coronavirus infections exceeded 50 million on Sunday, according to a Reuters tally, with a second wave of the virus in the past 30 days accounting for a quarter of the total.
HALLE, Belgium (AP) — In times when a pandemic unleashes death and poverty, the concept of what is essential to keep society functioning in a lockdown is gripping Europe.
Reuters) - U.S. coronavirus infections surged by at least 129,606 on Friday, according to a Reuters tally, the third consecutive daily rise of more than 100,000 cases as a third wave of COVID-19 sweeps the United States.
A long-awaited coronavirus vaccine could be available in roughly two months, according to drugmaker AstraZeneca, which is developing a treatment.
The Anglo-Swedish drugmaker is working with the University of Oxford to develop one of the most closely watched COVID-19 vaccines, which is in late stage trials in the U.S., the U.K. and other countries to determine its safety and effectiveness. Once those results are reported, regulators will have to approve the vaccine for widespread use.
AstraZeneca said it will analyze data from its vaccine trials in November and December. If the results look promising, it will move quickly to ramp up manufacturing and obtain government approval in the U.S. and elsewhere, Chief Executive Pascal Soriot said Thursday.
Recent Comments